Innate Pharma (ADR) - IPHA - stock price prediction, stock price target, analyst ratings from 4 analysts

Innate Pharma (ADR) has a share price target of US$ 6, revenue growth forecast of 238.7%, and profit growth estimate of 42.4% for FY26, based on top 4 analyst calls.